The Recent Development in the Diagnosis of Mycobacterium tuberculosis
Smart Medicine · 2025-06 · 4 (2)
DOI: 10.1002/smmd.70007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Smart Medicine, online erschienen am 25.04.2025. Verfasst von Nimet Temur und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy Department of Analytical Chemistry Erciyes University Kayseri Türkiye. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, Bilimsel Araştırma Projeleri, Erciyes Üniversitesi.
Abstract (Originalsprache)
Mycobacterium tuberculosis (MTB) remains a global health issue and continues to rank among the leading causes of death from infectious diseases worldwide. Its persistence is primarily attributed to the microorganism's challenging and time‐consuming diagnosis and treatment, which drives the need for new diagnostic tests. The development of rapid, highly sensitive point‐of‐care (POC) tests is crucial, as these tests address the limitations of traditional methods, which are lengthy and exhibit low sensitivity. Early and rapid diagnostic tests ensure timely diagnoses and treatments for individuals while playing a pivotal role in preventing the spread of MTB and curbing societal transmission. These diagnostic tests significantly impact TB diagnosis and treatment, potentially breaking the chain of transmission and presenting a promising step toward combating the infection. Rapid and accurate diagnostic tests for MTB detection continue to attract significant attention in the literature and show promise for widespread application. However, they face challenges such as limited accessibility and usability, particularly in underdeveloped countries. The implementation of rapid tests requires careful consideration of time and resource efficiency compared with traditional tests. This study reviews the diagnostic tests developed for MTB detection, tracing their evolution from the past to the present.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Pharmacy Department of Analytical Chemistry Erciyes University Kayseri Türkiye.
- Kayseri City Training and Research Hospital University of Health Science Kayseri Türkiye.
- Faculty of Medicine Department of Infectious Diseases and Clinical Microbiology Recep Tayyip Erdogan University Rize Türkiye.
- Faculty of Dentistry Department of Medical Biochemistry University of Nuh Naci Yazgan Kayseri Türkiye.
- Faculty of Pharmacy Department of Pharmaceutical Technology Zonguldak Bulent Ecevit University Zonguldak Türkiye.
- Faculty of Pharmacy Department of Analytical Chemistry Harran University Sanliurfa Türkiye.
ORCID-Profile: Esma Eryilmaz- Eren, Nilay Ildiz, Ismail Ocsoy
Förderung
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
- Bilimsel Araştırma Projeleri, Erciyes Üniversitesi
Zitieren
APA
Temur, N., Eren, E. E., Celik, I., Yıldız, I. E., Nisari, M., Unal, I. S., Celik, C., Ildiz, N., & Ocsoy, I. (2025). The Recent Development in the Diagnosis of Mycobacterium tuberculosis. Smart Medicine, 4(2). https://doi.org/10.1002/smmd.70007
Vancouver
Temur N, Eren EE, Celik I, Yıldız IE, Nisari M, Unal IS, et al. The Recent Development in the Diagnosis of Mycobacterium tuberculosis. Smart Medicine. 2025;4(2). doi:10.1002/smmd.70007
BibTeX
@article{Temur2025,
author = {Temur, Nimet and Eren, Esma Eryilmaz- and Celik, Ilhami and Yıldız, Ilknur E and Nisari, Mustafa and Unal, Ilay S and Celik, Cagla and Ildiz, Nilay and Ocsoy, Ismail},
title = {The Recent Development in the Diagnosis of Mycobacterium tuberculosis},
journal = {Smart Medicine},
year = {2025},
volume = {4},
number = {2},
doi = {10.1002/smmd.70007}
}
EUVIMED